Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells

[1]  A. Barr,et al.  A cell cycle centric view of tumour dormancy , 2023, British Journal of Cancer.

[2]  Lei Zhong,et al.  Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse , 2023, International journal of molecular sciences.

[3]  Yankun Liu,et al.  RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer , 2022, Cell & bioscience.

[4]  Yang Yang,et al.  HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction , 2022, International journal of biological sciences.

[5]  Bin Wang,et al.  HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway , 2022, Cell Death & Disease.

[6]  M. Zampieri,et al.  Sorting‐free metabolic profiling uncovers the vulnerability of fatty acid β‐oxidation in in vitro quiescence models , 2022, Molecular systems biology.

[7]  R. Cerione,et al.  Elucidation of an mTORC2-PKC-NRF2 pathway that sustains the ATF4 stress response and identification of Sirt5 as a key ATF4 effector , 2022, Cell death discovery.

[8]  T. Sjöblom,et al.  Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions , 2022, Cancers.

[9]  Yichun Wang,et al.  3D cell cultures toward quantitative high-throughput drug screening. , 2022, Trends in pharmacological sciences.

[10]  H. Ding,et al.  ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction , 2021, Cell reports.

[11]  A. Regev,et al.  Cycling cancer persister cells arise from lineages with distinct programs , 2021, Nature.

[12]  M. Muñoz-Centeno,et al.  Coupling Between Cell Cycle Progression and the Nuclear RNA Polymerases System , 2021, Frontiers in Molecular Biosciences.

[13]  R. Garzon,et al.  ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia. , 2021, Molecular cell.

[14]  F. Kosari,et al.  Three-dimensional microscale hanging drop arrays with geometric control for drug screening and live tissue imaging , 2021, Science Advances.

[15]  Lei Jin,et al.  Towards a Framework for Better Understanding of Quiescent Cancer Cells , 2021, Cells.

[16]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[17]  Xi Chen,et al.  Endoplasmic reticulum stress signals in the tumour and its microenvironment , 2020, Nature Reviews Cancer.

[18]  C. Reilly,et al.  Transient Receptor Potential Ankyrin-1 and Vanilloid-3 Differentially Regulate Endoplasmic Reticulum Stress and Cytotoxicity in Human Lung Epithelial Cells After Pneumotoxic Wood Smoke Particle Exposure , 2020, Molecular Pharmacology.

[19]  Ching-Feng Cheng,et al.  Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer , 2020, Frontiers in Endocrinology.

[20]  Stephanie Herman,et al.  Descriptive Proteome Analysis to Investigate Context-Dependent Treatment Responses to OXPHOS Inhibition in Colon Carcinoma Cells Grown as Monolayer and Multicellular Tumor Spheroids , 2020, ACS omega.

[21]  Yu Xia,et al.  Activating transcription factor 3 coordinates differentiation of cardiac and hematopoietic progenitors by regulating glucose metabolism , 2020, Science Advances.

[22]  Neil Vasan,et al.  A view on drug resistance in cancer , 2019, Nature.

[23]  Fabian J Theis,et al.  Generalizing RNA velocity to transient cell states through dynamical modeling , 2019, Nature Biotechnology.

[24]  A. Sartore-Bianchi,et al.  Treatment sequencing in metastatic colorectal cancer. , 2019, European journal of cancer.

[25]  Sandy L. Klemm,et al.  Chromatin accessibility and the regulatory epigenome , 2019, Nature Reviews Genetics.

[26]  G. Tonon,et al.  Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus , 2018, The EMBO journal.

[27]  Hanchen Xu,et al.  Drug resistance and new therapies in colorectal cancer , 2018, World journal of gastroenterology.

[28]  Erik Sundström,et al.  RNA velocity of single cells , 2018, Nature.

[29]  Zev J. Gartner,et al.  DoubletFinder: Doublet detection in single-cell RNA sequencing data using artificial nearest neighbors , 2018, bioRxiv.

[30]  Ziyan Zhao,et al.  A Novel Multiple-Read Screen for Metabolically Active Compounds Based on a Genetically Encoded FRET Sensor for ATP , 2018, SLAS discovery : advancing life sciences R & D.

[31]  Dazhi Wang,et al.  High Expression of PLOD1 Drives Tumorigenesis and Affects Clinical Outcome in Gastrointestinal Carcinoma. , 2018, Genetic testing and molecular biomarkers.

[32]  Howard Y. Chang,et al.  Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneity , 2018, bioRxiv.

[33]  Fabiana M. Duarte,et al.  Molecular mechanisms driving transcriptional stress responses , 2018, Nature Reviews Genetics.

[34]  Z. Shang,et al.  Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism, cell cycle, and survival , 2018, Cell Death & Disease.

[35]  M. Greenberg,et al.  AP-1 Transcription Factors and the BAF Complex Mediate Signal-Dependent Enhancer Selection. , 2017, Molecular cell.

[36]  D. Brömme,et al.  A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K , 2017, PloS one.

[37]  A. Petcherski,et al.  Cell cycle–related metabolism and mitochondrial dynamics in a replication-competent pancreatic beta-cell line , 2017, Cell cycle.

[38]  Carson C. Thoreen,et al.  mTORC1 Balances Cellular Amino Acid Supply with Demand for Protein Synthesis through Post-transcriptional Control of ATF4 , 2017, Cell reports.

[39]  R. Hoffman,et al.  Cell-cycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging , 2017, Cell cycle.

[40]  Mårten Fryknäs,et al.  Iron chelators target both proliferating and quiescent cancer cells , 2016, Scientific Reports.

[41]  K. Kultima,et al.  Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids. , 2016, Cell chemical biology.

[42]  Grace X. Y. Zheng,et al.  Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.

[43]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[44]  M. Bouvet,et al.  Spatial–temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness , 2014, Cell cycle.

[45]  Fidel Ramírez,et al.  deepTools: a flexible platform for exploring deep-sequencing data , 2014, Nucleic Acids Res..

[46]  Q. Wu,et al.  MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1 , 2014, Cell Death and Disease.

[47]  V. Gogvadze,et al.  Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments , 2014, Nature Communications.

[48]  G. Zhang,et al.  Autophagy Inhibition Contributes to the Synergistic Interaction between EGCG and Doxorubicin to Kill the Hepatoma Hep3B Cells , 2014, PloS one.

[49]  Howard Y. Chang,et al.  Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.

[50]  Jin-Ming Yang,et al.  Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells , 2013, Autophagy.

[51]  Durga Prasad Mishra,et al.  Therapeutic targeting of cancer cell cycle using proteasome inhibitors , 2012, Cell Division.

[52]  T. Sjöblom,et al.  The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapy. , 2012, European journal of cancer.

[53]  J. McClintick,et al.  The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress , 2011, Molecular biology of the cell.

[54]  A. Sikalidis,et al.  Gene expression and integrated stress response in HepG2/C3A cells cultured in amino acid deficient medium , 2011, Amino Acids.

[55]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[56]  T. Hunter,et al.  Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors , 2010, Cell cycle.

[57]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[58]  Riitta Lahesmaa,et al.  Activating Transcription Factor 3 Is a Positive Regulator of Human IFNG Gene Expression , 2010, The Journal of Immunology.

[59]  R. Kanthan,et al.  Expression of cell cycle proteins in male breast carcinoma , 2010, World journal of surgical oncology.

[60]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[61]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[62]  D. Newton,et al.  ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC , 2009, BMC Cancer.

[63]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[64]  Tsonwin Hai,et al.  Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination , 2005, The EMBO journal.

[65]  J. W. Brewer,et al.  PERK mediates cell-cycle exit during the mammalian unfolded protein response. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. Sherr,et al.  Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  M. Montminy,et al.  Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene , 1987, Nature.